Share this to:

Support & Insight for the Autumn of Life

New Treatment for Chorea from Huntington’s Dementia

Join HDSA for a research webinar, discussing the new FDA-approved medication for treatment of chorea associated with HD in adults.
HDSA logo

HDSA Research Webinar: New Treatment for Chorea Associated with HD: On Friday, December 8 at 12:00 PM Eastern, join HDSA for a research webinar in which Neurocrine Biosciences, Inc. will discuss their new medication recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of chorea associated with HD in adults.

Click Here To Register

Speakers include Grace Liang, Vice President of Clinical Development, Neurocrine Biosciences, Jaeson Kaplan, Executive Director of Market Access, Neurocrine Biosciences, and Erin Furr Stimming, M.D., FAAN, FANA, Principal Investigator, Huntington Study Group and Professor of Neurology, McGovern Medical School, UTHealth Houston.

Notify of

Inline Feedbacks
View all comments
B. Berger

B. Berger

Visit Our Pages On:


This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chaffe, the important articles & videos from each week’s river of news. With a new post on Alzheimer’s or dementia appearing on the internet every 7 minutes, the site’s focus on the best information has been a help to many over the past 15 years. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor


No data was found
Would love your thoughts, please comment.x
News, Treatments, Care Tips

Subscribe To The Weekly Newsletter

videos & articles on Research & Prevention
News to Get at the Truth

Subscribe To Our Weekly Newsletter